2021
DOI: 10.3390/ijms22062880
|View full text |Cite
|
Sign up to set email alerts
|

Cannabinoid Receptors Overexpression in a Rat Model of Irritable Bowel Syndrome (IBS) after Treatment with a Ketogenic Diet

Abstract: The administration of a ketogenic diet (KD) has been considered therapeutic in subjects with irritable bowel syndrome (IBS). This study aimed to investigate the molecular mechanisms by which a low-carbohydrate diet, such as KD, can improve gastrointestinal symptoms and functions in an animal model of IBS by evaluating possible changes in intestinal tissue expression of endocannabinoid receptors. In rats fed a KD, we detected a significant restoration of cell damage to the intestinal crypt base, a histological … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
10
1

Year Published

2021
2021
2023
2023

Publication Types

Select...
6

Relationship

2
4

Authors

Journals

citations
Cited by 10 publications
(13 citation statements)
references
References 49 publications
(31 reference statements)
1
10
1
Order By: Relevance
“…As recently published elsewhere by our group, we have already demonstrated the effectiveness of KD in ameliorating intestinal membrane functions and gut mitochondrial biogenesis in the animal model of IBS, along with the inflammatory status [35,36].…”
Section: Discussionsupporting
confidence: 62%
See 1 more Smart Citation
“…As recently published elsewhere by our group, we have already demonstrated the effectiveness of KD in ameliorating intestinal membrane functions and gut mitochondrial biogenesis in the animal model of IBS, along with the inflammatory status [35,36].…”
Section: Discussionsupporting
confidence: 62%
“…Additionally, it is now accepted how altered communication between the gut and the brain can contribute to intestinal and psychological dysfunctions observed in IBS [4]. In this framework, and derived mainly from preliminary results in animal studies [34][35][36], KD could show some interesting therapeutic potentiality.…”
Section: Discussionmentioning
confidence: 99%
“…The pharmacological inhibition of FAAH has been shown to reduce inflammation and to promote gut healing ( Sasson et al, 2006 ). Cannabinoid receptors also mediate the low-carbohydrate diet-induced improvement in the gastro-intestinal function and provide protection to the intestinal crypt base ( Gigante et al, 2021 ). In the mouse model of chemical-induced colitis, CB1R protects from the pro-inflammatory responses, while the genetic deficiency of CB1R induces stronger inflammatory responses ( Massa et al, 2004 ).…”
Section: The Intestinal Endocannabinoid Systemmentioning
confidence: 99%
“…Several clinical studies have shown that KD a reduction of midlife mortality and a prolongation of health due to its ability to control body weight and its beneficial effects in the prevention of type 2 diabetes, cancer, and neurological diseases [3][4][5][6]. Recently, in a rat model of irritable bowel syndrome (IBS), KD was able to restore intestinal cell damage through the upregulation of endocannabinoids receptors (CB1-R and CB2-R) [7] improving intestinal permeability. Besides, the KD administration positively compensatory mechanisms able to reduce inflammation and oxidative stress in the gut, restoring mitochondrial function and baseline autophagy [7,8].…”
Section: Introductionmentioning
confidence: 99%
“…Recently, in a rat model of irritable bowel syndrome (IBS), KD was able to restore intestinal cell damage through the upregulation of endocannabinoids receptors (CB1-R and CB2-R) [7] improving intestinal permeability. Besides, the KD administration positively compensatory mechanisms able to reduce inflammation and oxidative stress in the gut, restoring mitochondrial function and baseline autophagy [7,8].…”
Section: Introductionmentioning
confidence: 99%